✦ LIBER ✦
Insights from pre-clinical studies for new combination treatment regimens with the Bcr-Abl kinase inhibitor imatinib mesylate (Gleevec/Glivec) in chronic myelogenous leukemia: a translational perspective
✍ Scribed by La Rosée, P; O’Dwyer, M E; Druker, B J
- Book ID
- 110055115
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 132 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.